AG

Anne Goffard Portfolio

Invests via Artal Group S.A. | Managed by Anne Goffard
Invests via Artal Group S.A.
Managed by Anne Goffard
Automatically Tracked
Tracking: 0 Updated: Jul 20 at 01:54 PM
Anne Goffard Profile

With a robust background in investment management, Anne Goffard has distinguished herself as a dynamic leader in the finance sector. Her career encompasses roles that highlight expertise in operational excellence and strategic initiatives across multiple market environments. Leveraging her experience, she contributes to enhancing organizational efficiencies while navigating complex business landscapes. Known for fostering collaborative relationships within the industry, her ability to drive performance outcomes and develop talent underlines her significance as a trailblazer in corporate leadership. As trends evolve, Goffard remains at the forefront of investment solutions relevant to contemporary markets.

With a robust background in investment management, Anne Goffard has distinguished herself as a dynamic leader in the finance sector. Her career encompasses roles that highlight expertise in operational excellence and strategic initiatives across multiple market environments. Leveraging her experience, she contributes to enhancing organizational efficiencies while navigating complex business landscapes. Known for fostering collaborative relationships within the industry, her ability to drive performance outcomes and develop talent underlines her significance as a trailblazer in corporate leadership. As trends evolve, Goffard remains at the forefront of investment solutions relevant to contemporary markets.

Investment Philosophy & Strategy
Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
9.28%
Gain -0.12%
Monthly
0.02%
Yearly
0.2%
Drawdown
23.93%
$2.61B
Equity
Holdings
$2.61B
Investment
$2.54B
$72.87M
Profit -$3.08M
Realized
$0
Unrealized
$72.87M
Dividends
$82.44M

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
-0.12%
Profit
-$3.08M
Win %
66%
This Week
Compared To Last Week
Gain
-0.12%
Profit
-$3.08M
Win %
66%
This Month
Compared to last month
Gain
1.1%
Profit
$28.33M
Win %
66%
This Year
Compared to last year
Gain
3.14%
Profit
$79.45M
Win %
66%
Itaú Unibanco Holding S.A. Sponsored Preferred ADR logo
ITUB Itaú Unibanco Holding S.A. Sponsored Preferred ADR
+1.65%
+$524,606.56
Vipshop Holdings Ltd - ADR logo
VIPS Vipshop Holdings Ltd - ADR
+1.55%
+$2.07M
Ironwood Pharmaceuticals Inc. logo
IRWD Ironwood Pharmaceuticals Inc.
+0.39%
+$3,884.3
HCA Healthcare Inc. logo
HCA HCA Healthcare Inc.
+0.19%
+$138,000
Morgan Stanley logo
MS Morgan Stanley
+0.07%
+$77,495
Meritor Inc logo
MTOR Meritor Inc
+0.03%
+$17,500
logo
594960163
0%
$0
Acorda Therapeutics Inc logo
ACOR Acorda Therapeutics Inc
0%
$0
Affymetrix, Inc. logo
AFFX Affymetrix, Inc.
0%
$0
logo
AGEN
0%
$0
logo
AMRN
0%
$0
logo
ARRY
0%
$0
logo
AUXL
0%
$0
logo
AVNR
0%
$0
logo
BIOD
0%
$0
logo
CERE
0%
$0
logo
CJES
0%
$0
logo
CPRH
0%
$0
logo
ESRX
0%
$0
logo
FURX
0%
$0
ImmunoGen Inc logo
IMGN ImmunoGen Inc
0%
$0
logo
ONXX
0%
$0
logo
POT
0%
$0
US Silica Holdings Inc logo
SLCA US Silica Holdings Inc
0%
$0
logo
SMT
0%
$0
logo
WW
0%
$0
XOMA Corporation logo
XOMA XOMA Corporation
0%
$0
BRF S.A. ADR logo
BRFS BRF S.A. ADR
-11.52%
-$294,800
Pacific Biosciences of California, Inc. logo
PACB Pacific Biosciences of California, Inc.
-3.82%
-$11,000
Lexicon Pharmaceuticals, Inc. logo
LXRX Lexicon Pharmaceuticals, Inc.
-3.77%
-$3.22M
Nektar Therapeutics Inc. logo
NKTR Nektar Therapeutics Inc.
-2.58%
-$483,472
Apple Inc. logo
AAPL Apple Inc.
-1.24%
-$1.15M
Bank of America Corporation logo
BAC Bank of America Corporation
-1.12%
-$548,000
Arcos Dorados Holdings Inc. logo
ARCO Arcos Dorados Holdings Inc.
-1.03%
-$74,213.9
Beazer Homes USA Inc. logo
BZH Beazer Homes USA Inc.
-0.68%
-$22,500
NovaGold Resources Inc. logo
NG NovaGold Resources Inc.
-0.68%
-$52,500
Standard Biotools Inc. logo
LAB Standard Biotools Inc.
-0.57%
-$1,595.78
Cementos Pacasmayo S.A.A. - ADR logo
CPAC Cementos Pacasmayo S.A.A. - ADR
-0.43%
-$16,957.5
YPF S.A. Sponsored ADR logo
YPF YPF S.A. Sponsored ADR
-0.36%
-$108,000
Biomarin Pharmaceutical Inc. logo
BMRN Biomarin Pharmaceutical Inc.
-0.25%
-$52,500
Lamar Advertising Company logo
LAMR Lamar Advertising Company
-0.23%
-$114,000
MetLife Inc. logo
MET MetLife Inc.
-0.15%
-$138,286.5
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
42
Longs Won
13/42 30%
Profit Factor
1.13
Profitability
Shorts Won
0/0 0%
Standard Deviation
$83.08M
Average Win
$48.51M
Best Trade
(Jul 20) $130.07M
Sharpe Ratio
0
Average Loss
-$19.23M
Worst Trade
(Jul 20) -$480.94M
Z-Score
-2 (98.72%)
Commissions
$0
Avg. Trade Length
14y 3w 2d
Expectancy
$1.73M
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% 5.09% 12.48% 21.08% 30.58% 40.8% 51.65% 63.05% 74.93% 87.26%
Consecutive Losing Trades 136 122 109 95 82 68 54 41 27 14
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
FAQ
Which stocks have generated the highest profits for Anne Goffard?
The largest contributions to the portfolio's profits come from the following stocks: MetLife Inc - $16.35M, Lamar Advertising Company - $15.26M, Vipshop Holdings Ltd - ADR - $14.09M, Morgan Stanley - $12.15M, and Bank of America Corporation - $6.51M. These positions have been the main drivers of growth and have significantly impacted the investor's overall performance.
What dividends does Anne Goffard's portfolio generate?
The portfolio generates substantial dividend income, with a total of $82.44M earned over time. The largest contributors to dividend income include MetLife Inc - $16.35M, Lamar Advertising Company - $15.26M, Vipshop Holdings Ltd - ADR - $14.09M, Morgan Stanley - $12.15M, and Bank of America Corporation - $6.51M. This indicates that dividends play a meaningful role in the investor's overall strategy.
How stable are Anne Goffard's monthly returns?
Anne Goffard's monthly returns show a mixed pattern. Some months are relatively calm, while others are noticeably stronger or weaker, which suggests that performance is not fully consistent over time. This points to a strategy that may offer attractive upside but can also experience uneven short-term results.
Can Anne Goffard's strategy be considered aggressive or moderate?
Anne Goffard's strategy can be described as moderate. It balances growth potential with risk management, showing a willingness to accept some volatility while still maintaining a relatively structured and diversified approach.
Should beginners follow Anne Goffard's strategy?
Anne Goffard's strategy is probably not ideal for beginners. The combination of risk, volatility, or portfolio complexity may make it harder to follow and understand without prior experience. Users who are new to investing may find it challenging to replicate or tolerate the performance swings.
Account USV